Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2026-07-22 16:10:04 ET · period of report 2026-07-20 · accession 0001193125-26-312410 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-22 16:10 | 2026-07-20 | IRWD | Silber Jeffrey | SVP, CMO, Head-Res, Drug | A - Grant | $0.00 | +137.0K | 137.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-07-20 | A | A | 137,036 | $0.00 | 137,036 | D | — | — | (F1) The restricted stock unit award, granted as a new hire award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof. |